Blood cancers

Can a new biomarker in myeloma lead to faster treatment for patients who need it most?

Professor Claudine Bonder is head of the Vascular Biology & Cell Trafficking laboratory at the University of South Australia’s Centre for Cancer Biology.

Read more

Can you sum up the aim of this project in 10 words? Advancing prognostic tests for patients with multiple myeloma who have the poorest survival outcomes. You’ve identified a cell adhesion protein associated with particularly aggressive disease in multiple myeloma. What did you find? Newly-diagnosed MM patients currently undergo lengthy genetic testing to match chromosomal ...

Already a member?

Login to keep reading.

© 2021 the limbic